FLT4 and breast cancer: Furthermore, we detected the expression of VEGFR3 in endothelial cells treated with breast cancer cell supernatant, and found that the supernatants of MB-MDA-231 cells knockdown USP12 and this inhibits the expression of VEGFR3 protein in endothelial cells (Fig. S5B).